Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Endocrinology
Diabetes Mellitus, Type 2
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Clinical Research for Type 2 Diabetes
Type 2 Diabetes Research Opportunity
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you controlling your diabetes or is it controlling you?
From diagnosis to decision
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
Type 2 Diabetes Research Study (people not taking medications)
Type 2 Diabetes Research Study (people taking Actos® or Avandia®)
Type 2 diabetes
Type 2 diabetes
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
Do you have high blood sugars?
Type II Diabetes Research
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
Clinical Research for Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Are you newly diagnosed with Type 2 Diabetes and trying to control your glucose levels with diet and exercise alone?
Trouble with controlling your sugars?
Trouble with controlling your sugars?
Trouble with controlling your sugars?
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
High Blood Sugar Levels can affect Your Health.
Patients with type 2 diabetes needed for a clinical research trial.
Type II Diabetes Research
Type II Diabetes Research
Type II Diabetes Research
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Is Diabetes a
Part of Your Life?
Type 2 Diabetes: Giving Medication a Try
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Type 2 Diabetes Study for patients on Actos (proglitazone) only.
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.
Pediatric Type 2 Diabetes Study
Type II Diabetes / Renal Impairment Research Study
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A study to assess the effectiveness of PAP treatment on glycemic control (HbA1c) in patients with diabetes
A study to evaluate the performance of a new glucose meter.
Diabetes Type 2 study to evaluate efficacy of Albiglutide in combination with Metformin compared with Metformin alone.
Have you been diagnosed with Type ll Diabetes? Are you looking for treatment options?
Clinical Research Study for People with Type 2 Diabetes
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Do you have Type 2 Diabetes?
Do you have Type II Diabetes?
Do you have Type II Diabetes?
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type II Diabetes Research
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Diabetes Type II
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Concerned about your Diabetes? If so, a clinical research study may be an option.
Do you have type 2 diabetes mellitus?
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you unable to Manage your Type 2 Diabetes with Diet and Exercise Alone?
Are you unable to manage your Type 2 Diabetes?
Study of an investigational medication for the treatment of type 2 diabetes
Hypertension and Type 2 Diabetes Outpatient Study
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Diabetes Type 2
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Diabetes Type 2
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you unable to Manage your Type 2 Diabetes with Diet and Exercise Alone?
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type 2 Diabetes Study
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
Do You Have Type 2 Diabetes?
Type II Diabetes Research
Type II Diabetes Research
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
Type II Diabetes Research
A study to evaluate the efficacy of the study medication MK-0941 as an add on therapy to patients on long acting basal insulin.
Do you have type 2 diabetes?
A clinical research study is comparing two medications approved to treat
type 2 diabetes to see how each may better control your blood sugar levels. To qualify, you must be at
least 18 years old and taking oral metformin alone or with another oral diabetes drug for three months or
longer. Qualified participants will receive all study-related care and study medication at no cost, and may
be compensated for time and travel.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
ALTITUDE Diabetes Study CSPP100E2337
A New Insulin Treatment is on the Horizon
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are You Taking Insulin to Manage Your Type 2 Diabetes?
Are your blood sugars under control?
Blood sugar rising? Diet and exercise not working?
Can a time-release medicine better control your diabetes?
Can you tell me about the study drug?
Diabetes Shouldn’t Define You
Diabetic and Overweight?
Do you have type 2 diabetes?
Do you have Type 2 Diabetes? Consider Volunteering?
From diagnosis to decision. If you have type 2 diabetes there are a few things you should know
Have you been diagnosed with Type II Diabetes?
Interested in lowering your blood sugar without increasing your insulin?
Raise your hand if you have type 2 diabetes
Research Study for Type 2 Diabetics
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type 2 Diabetes
Type 2 Diabetes
Type 2 Diabetes
Clinical Research Study
Type 2 Diabetes and Metabolic Syndrome.
Type 2 Diabetes with Kidney Disease?
Type II Diabetes Study
When your type 2 diabetes is out of control, finding harmony is essential
You may be eligible to join the EMERGE STUDY if you
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A study evaluating the effectiveness in treating Type 2 Diabetes with sitagliptin(Januvia) in combination with pioglitazone(Actos) in those who have inadequate glycemic control
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
Diabetes Research
DIABETES TYPE 2 RESEARCH STUDY
TYPE II DIABETES RESEARCH STUDY
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
TYPE 2 DIABETES Study -- The Power of Two
A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination with Metformin in Subjects with Type 2 Diabetes.
A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and With Metformin Plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus.
A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus.
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Type II Diabetes Research
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
16 Million People in the U.S. Have Type II Diabetes. Are You One of Them?
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Do you have type 2 diabetes?
Type II Diabetes Research
Type II Diabetes Research
Type II Diabetes Research
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Do you have Diabetes?
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type 2 Diabetes (T2DM)
A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and Class II Heart Failure.
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Type II Diabetes Research
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A 26 week randomized, multinational, open labelled, 2 armed, parallel group, treat-to-target once daily treatment trial with insulin detemir versus insulin glargine, both in combination with metformin in subjects with type 2 diabetes.
A multi-center, randomized double-blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as monotherapy in patients with type 2 diabetes.
A muti-center, randomized double blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as add-on therapy to metformin in patients with type 2 diabetes.
A muti-center, randomized double blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as add-on therapy to metformin in patients with type 2 diabetes.
A phase 2 randomized two-stage open-label multi-center 24-week to evaluate the efficacy safety and tolerability of itca650 in subjects with type 2 diabetes mellitus
A randomized double blind, placebo-controlled parallel-group multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top of metformin in patients with type 2 diabetes not adequately controlled with metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Type II Diabetes Research
A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Current treatment not controlling your Diabetes?
Need help controlling your Type II Diabetes?
Overweight with Type II Diabetes?
Type II Diabetes that is not controlled by medication
Uncontrolled Type II Diabetes`
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Harmony, a Global Type 2 Diabetes Program
The GetGOAL-P Study to evaluate the effectiveness of an investigational medication for people with type 2 diabetes.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type II Diabetes Research
Uncontrolled Diabetes is no day at the beach!
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Have you been diagnosed with TYPE 2 DIABETES?
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Phase III Clinical Trial to Evaluate the Effectiveness of a DPP-IV Inhibitor as Adjuvant Therapy for Achieving Glycemic Control in Patients with Type II Diabetes
Type II Diabetes - Inhaled Insulin for the Control of Blood Sugar
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Aleglitazar in Patients With Type 2 Diabetes
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Aleglitazar in Patients With Type 2 Diabetes
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type II Diabetes Research
Type II Diabetes Research
Type II Diabetes Research
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Focused on Controlling Your Type 2 Diabetes?
Type 2 Diabetes
Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A study for newly diagnosed Type 2 diabetics or diabetics for whom diet and exercise are no longer enough
A study for people who have inadequately controlled Type 2 Diabetes
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Aleglitazar in Patients With Type 2 Diabetes
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Adult age 18-80 years with diabetes mellitus type 2 on metformin and pioglitazone.
Adults age 18-80 years with diabetes mellitus type 2 on metformin monotherapy or metformin in combination with a sulfonylurea.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type II Diabetes Research
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
Type II Diabetes Research
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Do You Have Type II Diabetes?
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
ALTITUDE Diabetes Study CSPP100E2337
An Adult Type 2 Diabetic Study
An Adult Type 2 Diabetic Study
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Diabetes: Do you have type 1 or type 2 diabetes? Or Do you have a relative with type 1 diabetes?
Diabetes: Have you recently been diagnosed with type 2 diabetes?
Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Aleglitazar in Patients With Type 2 Diabetes
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type II Diabetes Research
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Behavioral modifications and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
A 52-Week, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients with Type 2 Diabetes Mellitus Managed with Oral Hypoglycemic Agent(s)
CBT For Adherence and Depression in Diabetes
Seeking Volunteers ages 18-75 with Type 2 diabetes
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR MGH)
The Role of the Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
TODAY Study Group Genetics Protocol
Diabetes Title Type II
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Research Study for Type II Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
Type II Diabetes Research
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A study evaluating an investigational medication for type II diabetes.
A study evaluating an investigational medication for type II diabetes.
A study evaluating an investigational medication for type II diabetes.
A study evaluating an investigational medication for type II diabetes.
A study evaluating an investigational medication for type II diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A study to evaluate the effectiveness of an investigational medication for people with type II diabetes.
A study to lower the risk of cardiovascular and renal health problem in type II diabetics.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type II Diabetes Research
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
Do you have Type II Diabetes and Chronic Kidney Disease?
Clinical Research for Type 2 Diabetes
Type 2 Diabetes Research Study Diet Controlled
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A 16-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to compare the safety and efficacy of Starlix (nateglinide) vs. placebo in patients with type 2 diabetes who are inadequately controlled with basal insulin glargine in combination with metformin and/or thiazolidinedione (pioglitazone or rosiglitazone)
A Multi-center, Randomized, Open-label, Active Controlled, Parallel Arm Study to Compare the Efficacy of 12 Weeks of Treatment with Vildagliptin 100mg, qd to Thiazolidinedione (TZD) as Add-on Therapy in Patients with type 2 Diabetes Inadequately Controlled with Metformin Monotherapy in a Community-based Practice Setting
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you down in the dumps with your diabetes?
Pre-diabetes: Are you at risk?
The durability of twice daily insulin lispro low mixture compared to once daily insulin Glargine when added to existing oral therapy in patients with type 2 diabetes and inadequate glycemic control.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Are You a Type 2 Diabetic and Your Current Medications Are Just Not Enough?
Do you have diabetes?
Do You Have Type 2 Diabetes? Are Diet and Exercise Not Working?
When Your Type 2 Diabetes is Out of Control, Finding Harmony is Essential
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
ALTITUDE Diabetes Study CSPP100E2337
Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
DO YOU HAVE TYPE II DIABETES?
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type II Diabetes Research
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type II Diabetes Research
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
TINSAL-T2D (Targeting INflammation using SALsalate for Type 2 Diabetes Stage II)
Type 2 Diabetes Mellitus - Adults
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Clinical trial to test how different doses of a study drug can help people with Type 2 Diabetes
Are You Diabetic? Do You Have High Blood Pressure?
DIABETES TYPE 2
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus [H7U-MC-IDAU]
A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus [H7U-MC-IDAU]
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients with Type 2 Diabetes Treated with Once-Daily Insulin Glargine [H7U-MC-IDBA]
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Diabetes Study
Recently Diagnosed with Diabetes?
Research study seeking adults with diabetes and other cardiovascular risk factors to participate in a long-term trial that will treat blood sugar and either blood pressure or blood fats, attempting to prevent heart attack or stroke.
Research study seeking adults with diabetes and other cardiovascular risk factors to participate in a long-term trial that will treat blood sugar and either blood pressure or blood fats, attempting to prevent heart attack or stroke.
Research study seeking adults with diabetes and other cardiovascular risk factors to participate in a long-term trial that will treat blood sugar and either blood pressure or blood fats, attempting to prevent heart attack or stroke.
Suffering from Type II Diabetes?
The DURABLE Trial:
Assessing the DURAbility of Basal vs. Lispro Mix 25 Insulin Efficacy
The Durability of Twice-Daily Insulin Lispro Low Mixture
Compared to Once-Daily Insulin Glargine when
added to Existing Oral Therapy in Patients with Type 2 Diabetes and Inadequate Glycemic Control [F3Z-US-IOOV]
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type II Diabetes Research
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Diabetes - Type2
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Do you have high blood sugar?
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
DIABETES Research Study
DIABETES: Is Diabetes a Part of Your Life?
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
DIABETES: Are you frustrated with trying to control your blood sugar levels?
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Are you a diabetic patient taking medicine to treat your high cholesterol?
Are you on insulin and suffer from Type 2 diabetes?
DIABETES: Is Diabetes a Part of Your Life?
Do you suffer from Type 2 diabetes?
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
DIABETES Research Study
DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
DIABETES: Do you have Type 2 Diabetes? Are diet and exercise not working?
DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
DIABETES (TYPE 2) Research Study
DIABETES Research Study
DIABETES Research Study
DIABETES: Have you been living with Type II Diabetes?
DIABETES: If you have Diabetes, you may want to participate in a research study.
DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Type II Diabetes Research Study
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Volunteers Needed for a Clinical Research Trial of an Investigational Medication.
Are you a Type 2 Diabetic?
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
Type II Diabetes Research
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type II Diabetes Research
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type 2 Diabetes
Type 2 Diabetes
Type 2 Diabetes
Type 2 Diabetes
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
Type II Diabetes - Diet Controlled
Type II Diabetes on Single or Multiple Medications
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
Type II Diabetes Research
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
ALTITUDE Diabetes Study CSPP100E2337
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
Have HIGH BLOOD PRESSURE and DIABETES TYPE II? We need your help in a study to evaluate the efficacy and safety of Aliskiren administered in combination with Valsartan versus Valsartan alone.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Overweight? Type 2 Diabetes?
Type 2 Diabetes Research Study
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Are you overweight with type II diabetes?... You might qualify to participate in a new clinical study
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
ALTITUDE Diabetes Study CSPP100E2337
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Recently diagnosed with Type 2 diabetes?
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
One Year Study for Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
Type II Diabetes Research
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
DIABETES Research Study
Type II Diabetes Research
Frustrated with type 2 diabetes?
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Is Type 2 Diabetes a Part of Your Life?
Type 2 Diabetes?
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of taspoglutide (RO5073031) compared to placebo in obese patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy
A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week main treatment period and an extension assessing the efficacy and safety of AVE0010 on top of pioglitazone in patients with type 2 diabetes not adequately controlled with pioglitazone.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Diabetes (Type 2) Research
Diabetes Research: Inhaled Insulin
Do You Have Type 2 Diabetes?
Do you or someone you know suffer from Diabetes Type II?
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type 2 Diabetes Research
Type II Diabetes Research
When your Type 2 Diabetes is out of control, finding harmony is essential
Is Type 2 Diabetes a Part of Your Life?
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type 2 Diabetes (ages 65+) - Houston, TX
Type II Diabetes Research
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type II Diabetes Research
Type 2 Diabetes Research Study
Type 2 Diabetes Research Study
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type II Diabetes Research
Type II Diabetes Research
A 4-Week, Multicenter, Randomized, Double-Blind, Phase 3b Trial to Evaluate the Efficacy of Saxagliptin in Combination With Metformin XR 1500 mg Versus Uptitrated Metformin XR to 2000 mg in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise and a Stable Dose of Metformin XR 1500 mg
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.
Diabetes & Weight Loss Research Study
Diabetes Research
Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.
Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
Someday, instead of thinking and Diabetes medication every day of the week, it might only have to be one day.
To Your Good Health! Especially for You!
Type 2 Diabetes Research Study
ALTITUDE Diabetes Study CSPP100E2337
Are you unable to manage your Type 2 Diabetes with diet and exercise alone?
You may be eligible to participate in a clinical research study.
If you have Type 2 Diabetes, and are between 18 and 80 years of age, and are currently treated with metformin, you may qualify to participate.
Raise your hand if you have Type 2 Diabetes!
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you having a hard time controlling your Diabetes?
Diabetes Type 2: Could you have type 2 diabetes?
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
Type II Diabetes- Patients currently taking Metformin
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
Diabetes
Are you dealing with 'Sugar' (Diabetes)?
Volunteers 22-64 with DM2 needed for Kidney Study
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
This research study is being done to compare the effects of three different approved drugs for high blood pressure in patients that have type 2 diabetes and who are taking medications for high blood pressure to determine the effect of each approved blood pressure drug on blood sugar levels.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairmant
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
Are You Taking Insulin Shots or a Combination of Pills and Insulin Shots for Treatment of Type 2 Diabetes?
Diabetes: Inhaled Insulin Research
Diabetes: Are you taking ACTOS (pioglitazone) or AVANDIA (rosiglitazone) for Type 2 Diabetes?
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.
Research Study (#08186) Type 2 Diabetes
Research Study (#09060) Type 2 diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study to Evaluate the Effect of GK Activator (2) on QT Interval in Patients With Type 2 Diabetes Mellitus.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Multiple Ascending Dose Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride.
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Multiple Ascending Dose Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Drug-Drug Interaction Study of GK Activator (2) and Ethanol in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Type 2 Diabetic Patients
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
A Study to Evaluate the Effect of GK Activator (2) on QT Interval in Patients With Type 2 Diabetes Mellitus.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of Aleglitazar in Patients With Type 2 Diabetes
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Intensive self-monitoring blood glucose management added value in non-insulin treated type 2 diabetes mellitus patients.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controll
